Literature DB >> 35180412

Fluvoxamine for the treatment of COVID-19.

Michael G Dodds1, Eileen B Doyle2, Angela M Reiersen3, Fran Brown1, Craig R Rayner4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35180412      PMCID： PMC8846600          DOI： 10.1016/S2214-109X(22)00006-7

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  5 in total

1.  Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine exposure.

Authors:  A Panchaud; F Garcia-Bournissen; C Csajka; J H Kristensen; A Taddio; K F Ilett; E J Begg; S Ito
Journal:  Clin Pharmacol Ther       Date:  2011-04-27       Impact factor: 6.875

2.  Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19.

Authors:  Vikas P Sukhatme; Angela M Reiersen; Sharat J Vayttaden; Vidula V Sukhatme
Journal:  Front Pharmacol       Date:  2021-04-20       Impact factor: 5.810

3.  Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.

Authors:  Gilmar Reis; Eduardo Augusto Dos Santos Moreira-Silva; Daniela Carla Medeiros Silva; Lehana Thabane; Aline Cruz Milagres; Thiago Santiago Ferreira; Castilho Vitor Quirino Dos Santos; Vitoria Helena de Souza Campos; Ana Maria Ribeiro Nogueira; Ana Paula Figueiredo Guimaraes de Almeida; Eduardo Diniz Callegari; Adhemar Dias de Figueiredo Neto; Leonardo Cançado Monteiro Savassi; Maria Izabel Campos Simplicio; Luciene Barra Ribeiro; Rosemary Oliveira; Ofir Harari; Jamie I Forrest; Hinda Ruton; Sheila Sprague; Paula McKay; Alla V Glushchenko; Craig R Rayner; Eric J Lenze; Angela M Reiersen; Gordon H Guyatt; Edward J Mills
Journal:  Lancet Glob Health       Date:  2021-10-28       Impact factor: 38.927

4.  Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro.

Authors:  Senem Merve Fred; Suvi Kuivanen; Hasan Ugurlu; Plinio Cabrera Casarotto; Lev Levanov; Kalle Saksela; Olli Vapalahti; Eero Castrén
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

5.  Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the Sigma-1 receptor and autophagy.

Authors:  James Michael Brimson; Mani Iyer Prasanth; Dicson Sheeja Malar; Sirikalaya Brimson; Premrutai Thitilertdecha; Tewin Tencomnao
Journal:  Expert Opin Ther Targets       Date:  2021-07-08       Impact factor: 6.902
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.